Psyence Biomedical Ltd.
(PBM)
undefined
undefined%
At close: undefined
1.91
-1.04%
Pre-market Jan 08, 2025, 06:13 AM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 |
| Net Income | -51.16M | 8.01M | 8.23M |
| Depreciation & Amortization | 240.00 | n/a | n/a |
| Stock-Based Compensation | 317.88K | 221.29K | 332.07K |
| Other Working Capital | -1.28M | -54.44K | -504.88K |
| Other Non-Cash Items | 49.07M | -8.48M | -8.56M |
| Deferred Income Tax | n/a | n/a | n/a |
| Change in Working Capital | -1.17M | -54.44K | -504.88K |
| Operating Cash Flow | -2.95M | -519.60K | -839.17K |
| Capital Expenditures | -5.73K | n/a | n/a |
| Acquisitions | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | -255.00M |
| Sales Maturities Of Investments | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | -32.04K |
| Investing Cash Flow | -5.73K | n/a | -255.00M |
| Debt Repayment | 2.35M | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a |
| Other Financial Acitivies | n/a | 1.17M | -1.63M |
| Financial Cash Flow | 2.35M | 1.17M | 256.49M |
| Net Cash Flow | -601.09K | -519.61K | -4.16M |
| Free Cash Flow | -2.95M | -519.60K | -839.17K |